Your browser doesn't support javascript.
loading
Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy.
Pruller, Johanna; Hofer, Isabella; Ganassi, Massimo; Heher, Philipp; Ma, Michelle T; Zammit, Peter S.
Afiliação
  • Pruller J; King's College London, Randall Centre for Cell and Molecular Biophysics, London, SE1 1UL, UK. johanna.prueller@kcl.ac.uk.
  • Hofer I; King's College London, Randall Centre for Cell and Molecular Biophysics, London, SE1 1UL, UK.
  • Ganassi M; King's College London, Randall Centre for Cell and Molecular Biophysics, London, SE1 1UL, UK.
  • Heher P; King's College London, Randall Centre for Cell and Molecular Biophysics, London, SE1 1UL, UK.
  • Ma MT; King's College London, School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, London, SE1 7EH, UK.
  • Zammit PS; King's College London, Randall Centre for Cell and Molecular Biophysics, London, SE1 1UL, UK. peter.zammit@kcl.ac.uk.
Cancer Gene Ther ; 28(5): 544, 2021 May.
Article em En | MEDLINE | ID: mdl-33177625
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article